Evidence map›Paper›PMID 40554724›Full record

ReviewMagnetic resonance in medicine2025

MRI for biology-guided radiation therapy: Are we there yet? A summary of the 2024 ISMRM member-initiated session.

Sirisha Tadimalla, Jie Deng, Peter B Barker, Hyunsuk Shim, Stefan Reinsberg, Chenyang Liu, Jing Cai, Jonathan Goodwin, Leith Rankine, Yu-Feng Wang and 3 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Magnetic resonance in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Sirisha TadimallaInstitute of Medical Physics, The University of Sydney, Sydney, New South Wales, Australia.ORCID https://orcid.org/0000-0003-2054-055X
Jie DengDepartment of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Peter B BarkerThe Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID https://orcid.org/0000-0002-6410-7793
Hyunsuk ShimKennedy Krieger Institute, Baltimore, Maryland, USA.
Stefan ReinsbergDepartment of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada.ORCID https://orcid.org/0000-0002-0975-3776
Chenyang LiuDepartment of Health Technology and Informatics, Hong Kong Polytechnic University, Hong Kong, China.
Jing CaiDepartment of Health Technology and Informatics, Hong Kong Polytechnic University, Hong Kong, China.
Jonathan GoodwinRadiation Oncology Department, Calvary Mater Newcastle, Newcastle, New South Wales, Australia.
Leith RankineDepartment of Radiation Oncology, University of North Carolina, Chapel Hill, North Carolina, USA.
Yu-Feng WangInstitute of Medical Physics, The University of Sydney, Sydney, New South Wales, Australia.
Petra van HoudtDepartment of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Ralph P MasonPrognostic Imaging Research Laboratory, Department of Radiology, UT Southwestern Medical Center, Dallas, Texas, USA.
Zhaoyang FanDepartments of Radiology and Radiation Oncology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.ORCID https://orcid.org/0000-0002-2693-0260

Funding

UT Southwestern Medical Center Simmons Comprehensive Cancer CenterP30CA142543 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI Kathryn Ann O'Donnell · 2010 to 2026
$53.7M
Improved whole-brain spectroscopic MRI for radiation therapy planningU01CA264039 · NCI · EMORY UNIVERSITY · PI Lee Cooper, Eric Albert Mellon · 2022 to 2026
$3.1M
Multi-Task MR Simulation for Abdominal Radiation Treatment PlanningR01EB029088 · NIBIB · UNIVERSITY OF SOUTHERN CALIFORNIA · PI FAN, ZHAOYANG, YANG, WENSHA · 2020 to 2023
$2.5M
Cancer Institute NSW 2021/CBG0002CPRIT RP210099NCI NIH HHS P30 CA142543NCI NIH HHS U01 CA264039NIBIB NIH HHS R01 EB029088NIH HHS P30 CA142543NIH HHS R01 EB029088NIH HHS U01 CA264039Sydney Cancer Partners 2021/CBG0002
6 · The paper itself

Abstract

At the 2024 ISMRM Annual Meeting in Singapore, a member-initiated session on MRI for biology-guided radiation therapy (RT), endorsed by the ISMRM MR in RT Study Group, was successfully organized. The session convened a diverse group of global experts in quantitative MRI for RT, who presented the latest research on the technical development and clinical translation of various quantitative MRI techniques for biology-guided RT planning and delivery. The session highlighted clinical needs and a variety of MRI techniques, including MR spectroscopic imaging, oxygen-enhanced MRI, four-dimensional MR fingerprinting, dynamic contrast-enhanced MRI, and

Indexed as

Magnetic Resonance ImagingNeoplasmsRadiotherapy, Image-GuidedContrast MediaHumansRadiotherapy Planning, Computer-AssistedSingaporeContrast Media

Identifiers

PMID40554724
PMCPMC12309883

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.